Official Malaysian Government Website
Text size
Display
Reading
PRODUCT CATEGORIES
REGULATORY INFORMATION
MORE REGULATIONS
Reporting
Consumer Information
Safety Information
Health Professionals
General Information
New Products / Indication
QUEST List of Manufacturers / Wholesalers / Importers
Annual Reports
Newsletter
NPRA INFORMATION
Recognition & International Membership
Useful Links
Drug Control Authority (DCA)
Malaysian Adverse Drug Reactions Advisory Committee (MADRAC)
Directives
Written by Lisa Assakina · 21 December 2021
Direktif untuk semua produk yang mengandungi decitabine: Pengemaskinian sisip bungkusan dengan maklumat keselamatan berkaitan risiko differentiation syndrome
Document · PDF · 553 KB
This browser cannot display the document inline.
Open the PDF
Not yet rated
